Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis
Open Access
- 15 November 2017
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 1529
Abstract
Multiple sclerosis (MS) is characterized by macrophage accumulation and inflammatory infiltrates into the CNS contributing to demyelination. Because purinergic P2X7 receptor (P2X7R) is known to be abundantly expressed on cells of the hematopoietic lineage and of the nervous system, we further investigated its phenotypic expression in MS and experimental autoimmune encephalomyelitis conditions. By quantitative reverse transcription polymerase chain reaction and flow cytometry, we analyzed the P2X7R expression in human mononuclear cells of peripheral blood from stable and acute relapsing-remitting MS phases. Human monocytes were also challenged in vitro with pro-inflammatory stimuli such as the lipopolysaccharide, or the P2X7R preferential agonist 2′(3′)-O-(4 Benzoylbenzoyl)adenosine 5′-triphosphate, before evaluating P2X7R protein expression. Finally, by immunohistochemistry and immunofluorescence confocal analysis, we investigated the P2X7R expression in frontal cortex from secondary progressive MS cases. We demonstrated that P2X7R is present and inhibited on peripheral monocytes isolated from MS donors during the acute phase of the disease, moreover it is down-regulated in human monocytes after pro-inflammatory stimulation in vitro. P2X7R is instead up-regulated on astrocytes in the parenchyma of frontal cortex from secondary progressive MS patients, concomitantly with monocyte chemoattractant protein-1 chemokine, while totally absent from microglia/macrophages or oligodendrocytes, despite the occurrence of inflammatory conditions. Our results suggest that inhibition of P2X7R on monocytes and up-regulation in astrocytes might contribute to sustain inflammatory mechanisms in MS. By acquiring further knowledge about P2X7R dynamics and identifying P2X7R as a potential marker for the disease, we expect to gain insights into the molecular pathways of MS.Keywords
This publication has 67 references indexed in Scilit:
- P2Y12receptor is expressed on human microglia under physiological conditions throughout development and is sensitive to neuroinflammatory diseasesGlia, 2016
- P2Y12Receptor on the Verge of a Neuroinflammatory BreakdownMediators of Inflammation, 2014
- Spinal cord pathology is ameliorated by P2X7 antagonism in SOD1-G93A mouse model of amyotrophic lateral sclerosisDisease Models & Mechanisms, 2014
- The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF‐αEuropean Journal of Immunology, 2013
- Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosisJournal of Neuroimmunology, 2012
- Transient P2X7 Receptor Activation Triggers Macrophage Death Independent of Toll-like Receptors 2 and 4, Caspase-1, and Pannexin-1 ProteinsJournal of Biological Chemistry, 2012
- P2X7 receptors mediate ischemic damage to oligodendrocytesGlia, 2009
- Downregulation of P2X7receptor expression in rat oligodendrocyte precursor cells after hypoxia ischemiaGlia, 2008
- Astrocytic complexity distinguishes the human brainTrends in Neurosciences, 2006
- Exacerbation of Experimental Autoimmune Encephalomyelitis in P2X7R−/− Mice: Evidence for Loss of Apoptotic Activity in LymphocytesThe Journal of Immunology, 2006